These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21416130)

  • 1. Multiple hepatocellular adenomas in a patient with glycogen storage disease type I: various enhancement patterns in MRI with Gd-EOB-DTPA.
    Sakamoto A; Hayashi H; Sakamoto I; Isomoto I; Eguchi S; Takatsuki M; Kanematsu T; Abe K; Hayashi T; Uetani M
    Abdom Imaging; 2012 Apr; 37(2):239-43. PubMed ID: 21416130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
    Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
    J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
    Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
    J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience.
    Lee SA; Lee CH; Jung WY; Lee J; Choi JW; Kim KA; Park CM
    Magn Reson Imaging; 2011 Jan; 29(1):83-90. PubMed ID: 20832227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
    Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
    Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd-EOB-DTPA enhanced micro-MR imaging of hepatic tumors in H-ras 12V transgenic mice.
    Bang DH; Park SH; Jun HY; Moon HB; Kim SU; Yu DY; Yoon KH
    Acad Radiol; 2011 Jan; 18(1):13-9. PubMed ID: 20926317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of Budd-Chiari syndrome: Gd-EOB-DTPA-enhanced MR findings.
    Kitajima K; Yoshikawa T; Seo Y; Ohno Y; Yano Y; Miki A; Kanda T; Kanata N; Azuma T; Sugimura K
    Magn Reson Imaging; 2011 May; 29(4):579-83. PubMed ID: 21216550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of hepatocellular carcinoma which could be diagnosed with Gd-EOB-DTPA enhanced MRI].
    Ota H; Mikami K; Nagase A; Nagase H; Mukai R; Okada K; Ide Y; Maruyama K; Murata K; Yokouchi H; Tamai M; Kinuta M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2386-8. PubMed ID: 20037431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?
    Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():87-93. PubMed ID: 20616589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic Acid-enhanced magnetic resonance imaging findings of borderline lesions at high risk for progression to hypervascular classic hepatocellular carcinoma.
    Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kawai K; Kozaka K
    J Comput Assist Tomogr; 2011; 35(2):181-6. PubMed ID: 21412087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T2-weighted magnetic resonance imaging of the liver: evaluation of the effect in signal intensity after Gd-EOB-DTPA enhancement.
    Tamada T; Ito K; Yoshida K; Sone T; Murakami K; Kanki A; Watanabe S; Higashi H; Yamashita T
    J Comput Assist Tomogr; 2010; 34(2):182-6. PubMed ID: 20351500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver.
    Tamada T; Ito K; Ueki A; Kanki A; Higaki A; Higashi H; Yamamoto A
    J Magn Reson Imaging; 2012 Apr; 35(4):852-8. PubMed ID: 22127980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors.
    Tsuda N; Kato N; Murayama C; Narazaki M; Yokawa T
    Invest Radiol; 2004 Feb; 39(2):80-8. PubMed ID: 14734922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
    Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
    Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adult male patient with multiple adenomas and a hepatocellular carcinoma: mild glycogen storage disease type Ia.
    Cassiman D; Libbrecht L; Verslype C; Meersseman W; Troisi R; Zucman-Rossi J; Van Vlierberghe H
    J Hepatol; 2010 Jul; 53(1):213-7. PubMed ID: 20447711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation.
    Lerut JP; Ciccarelli O; Sempoux C; Danse E; deFlandre J; Horsmans Y; Sokal E; Otte JB
    Transpl Int; 2003 Dec; 16(12):879-84. PubMed ID: 12904843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte-specific magnetic resonance imaging contrast agents.
    Fidler J; Hough D
    Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging.
    Tsuda N; Okada M; Murakami T
    Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.